\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ healthy\\ male\\ with\\ 50\\-60\\ erythematous\\ edematous\\ papules\\,\\ annular\\ plaques\\,\\ and\\ large\\ confluent\\ plaques\\,\\ located\\ on\\ chest\\,\\ back\\ arms\\,\\ knees\\,\\ and\\ forehead\\.\\ no\\ anesthesia\\,\\ nerve\\ enlargement\\,\\ or\\ atrophy\\ noted\\.\ \(0\)\
\-\ laboratory\\:\\ \\ rpr\\-nr\\,\\ lft\\-wnl\\,\\ esr\\-9\\,\\ wbc\\-6\\.8\\,\\ ana\\-neg\ \(0\)\
\-\ histopathology\\:\\ h\\&e\\/fite\\.\\ well\\ formed\\ linear\\ and\\ round\\ granulomas\\ of\\ slightly\\ foamy\\ macrophages\\ with\\ a\\ diffuse\\ dermal\\ lymphohistiocytic\\ infiltrate\\.\\ few\\ plasma\\ cells\\.\\ fite\\:\\ numerous\\ organisms\\ and\\ globi\\.\ \(0\)\
\-\ referral\\ to\\ san\\ diego\\ county\\â\\€\\™s\\ public\\ health\\ hansen\\â\\€\\™s\\ disease\\ clinic\\ and\\ begun\\ on\\ rifampin\\,\\ dapsone\\,\\ lamprene\\,\\ and\\ prednisone\\.\ \(0\)\
\-\ borderline\\ lepromatous\\ leprosy\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#4\\)\ \(0\)\
\-\ submitted\\ by\\:\\ lcdr\\ bradley\\ s\\.\\ graham\\,\\ mc\\,\\ usnr\\;\\ cdr\\ david\\ j\\.\\ barnette\\,\\ jr\\.\\,\\ mc\\,\\ usn\ \(0\)\
\-\ patient\\ with\\ 3\\ month\\ history\\ of\\ spreading\\ annular\\ plaques\\ on\\ chest\\,\\ back\\,\\ arms\\,\\ and\\ face\\.\\ initially\\ asmptomatic\\ but\\ in\\ last\\ 3\\-4\\ weeks\\ has\\ noticed\\ increasing\\ amount\\ of\\ paresthesia\\ and\\ variable\\ anesthesia\\ within\\ the\\ plaques\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plaques\\:\\ 0\\.10208485895469407\ \(0\)\
\-\ anesthesia\\:\\ 0\\.060748922011094636\ \(0\)\
\-\ annular\\:\\ 0\\.056568533682891296\ \(0\)\
\-\ mc\\:\\ 0\\.05357065170263292\ \(0\)\
\-\ arms\\:\\ 0\\.05104242947734704\ \(0\)\
\-\ rpr\\-nr\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ lft\\-wnl\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ esr\\-9\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ wbc\\-6\\.8\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ ana\\-neg\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ e\\/fite\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ lamprene\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ lepromatous\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ barnette\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ fite\\:\\ 0\\.043435140339072476\ \(0\)\
\-\ hansen\\:\\ 0\\.043435140339072476\ \(0\)\
\-\ dapsone\\:\\ 0\\.043435140339072476\ \(0\)\
\-\ asmptomatic\\:\\ 0\\.043435140339072476\ \(0\)\
\-\ globi\\:\\ 0\\.04126687772886838\ \(0\)\
\-\ diego\\:\\ 0\\.04126687772886838\ \(0\)\
\-\ leprosy\\:\\ 0\\.04126687772886838\ \(0\)\
\-\ cdr\\:\\ 0\\.04126687772886838\ \(0\)\
\-\ foamy\\:\\ 0\\.039728470924313405\ \(0\)\
\-\ lymphohistiocytic\\:\\ 0\\.039728470924313405\ \(0\)\
\-\ county\\:\\ 0\\.039728470924313405\ \(0\)\
\-\ bradley\\:\\ 0\\.039728470924313405\ \(0\)\
\-\ public\\:\\ 0\\.038535189901242765\ \(0\)\
\-\ graham\\:\\ 0\\.038535189901242765\ \(0\)\
\-\ jr\\.\\:\\ 0\\.038535189901242765\ \(0\)\
\-\ 50\\-60\\:\\ 0\\.03756020831410932\ \(0\)\
\-\ rifampin\\:\\ 0\\.03756020831410932\ \(0\)\
\-\ lcdr\\:\\ 0\\.036735873127867295\ \(0\)\
\-\ usnr\\:\\ 0\\.036735873127867295\ \(0\)\
\-\ usn\\:\\ 0\\.03602180150955434\ \(0\)\
\-\ spreading\\:\\ 0\\.03602180150955434\ \(0\)\
\-\ david\\:\\ 0\\.03539194570390523\ \(0\)\
\-\ \\,\\:\\ 0\\.03474353782040052\ \(0\)\
\-\ paresthesia\\:\\ 0\\.03385353889935025\ \(0\)\
\-\ san\\:\\ 0\\.033425503029438294\ \(0\)\
\-\ begun\\:\\ 0\\.033425503029438294\ \(0\)\
\-\ macrophages\\:\\ 0\\.03302920371310823\ \(0\)\
\-\ plasma\\:\\ 0\\.030860941102904143\ \(0\)\
\-\ dermal\\:\\ 0\\.030612170965819155\ \(0\)\
\-\ \\:\\:\\ 0\\.030221251764456284\ \(0\)\
\-\ back\\:\\ 0\\.030150442089277828\ \(0\)\
\-\ confluent\\:\\ 0\\.030146869484591186\ \(0\)\
\-\ borderline\\:\\ 0\\.030146869484591186\ \(0\)\
\-\ papules\\:\\ 0\\.029718833614679228\ \(0\)\
\-\ forehead\\:\\ 0\\.029718833614679228\ \(0\)\
\-\ granulomas\\:\\ 0\\.029322534298349166\ \(0\)\
\-\ formed\\:\\ 0\\.028284266841445648\ \(0\)\
\-\ edematous\\:\\ 0\\.0279786068743871\ \(0\)\
\-\ organisms\\:\\ 0\\.027689477348877608\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.02731579400690327\ \(0\)\
\-\ infiltrate\\:\\ 0\\.027154271688145076\ \(0\)\
\-\ prednisone\\:\\ 0\\.027028440151192167\ \(0\)\
\-\ submitted\\:\\ 0\\.027028440151192167\ \(0\)\
\-\ j\\.\\:\\ 0\\.026905501551060088\ \(0\)\
\-\ s\\.\\:\\ 0\\.02678532585131646\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.02678532585131646\ \(0\)\
\-\ erythematous\\:\\ 0\\.02655278514575636\ \(0\)\
\-\ knees\\:\\ 0\\.02655278514575636\ \(0\)\
\-\ s\\:\\ 0\\.02621141889962125\ \(0\)\
\-\ referral\\:\\ 0\\.025910302194729288\ \(0\)\
\-\ 1997\\:\\ 0\\.0256158648835901\ \(0\)\
\-\ histopathology\\:\\ 0\\.02552121473867352\ \(0\)\
\-\ seminar\\:\\ 0\\.025428210766952293\ \(0\)\
\-\ health\\:\\ 0\\.025336796684816996\ \(0\)\
\-\ uniformed\\:\\ 0\\.025158527057717577\ \(0\)\
\-\ noticed\\:\\ 0\\.02498600907794099\ \(0\)\
\-\ services\\:\\ 0\\.024656822484361136\ \(0\)\
\-\ dermatology\\:\\ 0\\.024656822484361136\ \(0\)\
\-\ variable\\:\\ 0\\.02434673019746087\ \(0\)\
\-\ h\\:\\ 0\\.024053638023690843\ \(0\)\
\-\ atrophy\\:\\ 0\\.023576466185573502\ \(0\)\
\-\ face\\:\\ 0\\.022409334816482496\ \(0\)\
\-\ chest\\:\\ 0\\.021868759358903943\ \(0\)\
\-\ healthy\\:\\ 0\\.020602533656184977\ \(0\)\
\-\ few\\:\\ 0\\.02056526804486897\ \(0\)\
\-\ numerous\\:\\ 0\\.02049150696394739\ \(0\)\
\-\ clinic\\:\\ 0\\.020418749466322904\ \(0\)\
\-\ round\\:\\ 0\\.019740932858626947\ \(0\)\
\-\ last\\:\\ 0\\.019522633422689756\ \(0\)\
\-\ linear\\:\\ 0\\.01937198702179833\ \(0\)\
\-\ amount\\:\\ 0\\.019082857496288835\ \(0\)\
\-\ located\\:\\ 0\\.0188085618043768\ \(0\)\
\-\ increasing\\:\\ 0\\.018728943555747116\ \(0\)\
\-\ initially\\:\\ 0\\.01859882537040203\ \(0\)\
\-\ slightly\\:\\ 0\\.018471798172497715\ \(0\)\
\-\ cells\\:\\ 0\\.0183232443537433\ \(0\)\
\-\ enlargement\\:\\ 0\\.01813138185286147\ \(0\)\
\-\ \\#\\:\\ 0\\.017923457855298867\ \(0\)\
\-\ laboratory\\:\\ 0\\.01684006275857789\ \(0\)\
\-\ nerve\\:\\ 0\\.01646495254806046\ \(0\)\
\-\ \\&\\:\\ 0\\.01605020263177236\ \(0\)\
\-\ diffuse\\:\\ 0\\.013834264280081898\ \(0\)\
\-\ month\\:\\ 0\\.013709168667382938\ \(0\)\
\-\ weeks\\:\\ 0\\.012969399769524857\ \(0\)\
\-\ 4\\:\\ 0\\.012732470081171364\ \(0\)\
\-\ on\\:\\ 0\\.011613224797306334\ \(0\)\
\-\ physical\\:\\ 0\\.011211258126102878\ \(0\)\
\-\ noted\\:\\ 0\\.010831129350013869\ \(0\)\
\-\ \\;\\:\\ 0\\.010831129350013869\ \(0\)\
\-\ 3\\:\\ 0\\.010700403886131228\ \(0\)\
\-\ well\\:\\ 0\\.010337331299297599\ \(0\)\
\-\ exam\\:\\ 0\\.010038684170853145\ \(0\)\
\-\ case\\:\\ 0\\.009997349908381126\ \(0\)\
\-\ large\\:\\ 0\\.00999220551781326\ \(0\)\
\-\ but\\:\\ 0\\.009746006957398596\ \(0\)\
\-\ within\\:\\ 0\\.0087172802587491\ \(0\)\
\-\ has\\:\\ 0\\.008581283264675282\ \(0\)\
\-\ male\\:\\ 0\\.008263131218649588\ \(0\)\
\-\ and\\:\\ 0\\.007700920031324853\ \(0\)\
\-\ by\\:\\ 0\\.007608935311469918\ \(0\)\
\-\ disease\\:\\ 0\\.007469184712383444\ \(0\)\
\-\ history\\:\\ 0\\.006311307688273173\ \(0\)\
\-\ or\\:\\ 0\\.005355736625474372\ \(0\)\
\-\ no\\:\\ 0\\.004601305618736909\ \(0\)\
\-\ patient\\:\\ 0\\.00458070551292186\ \(0\)\
\-\ \\(\\:\\ 0\\.00386289693178535\ \(0\)\
\-\ \\)\\:\\ 0\\.00381570958349361\ \(0\)\
\-\ to\\:\\ 0\\.002283786676165702\ \(0\)\
\-\ in\\:\\ 0\\.0022534611237446786\ \(0\)\
\-\ a\\:\\ 0\\.002120854555179686\ \(0\)\
\-\ with\\:\\ 0\\.0018770723436880709\ \(0\)\
\-\ of\\:\\ 0\\.0018690449325880498\ \(0\)\
\-\ \\.\\:\\ 0\\.001708533822866933\ \(0\)\
\-\ the\\:\\ 0\\.000739300987719924\ \(0\)\
